Does REVLIMID Cause Lung neoplasm malignant? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Lung neoplasm malignant have been filed in association with REVLIMID. This represents 0.1% of all adverse event reports for REVLIMID.
7
Reports of Lung neoplasm malignant with REVLIMID
0.1%
of all REVLIMID reports
4
Deaths
2
Hospitalizations
How Dangerous Is Lung neoplasm malignant From REVLIMID?
Of the 7 reports, 4 (57.1%) resulted in death, 2 (28.6%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVLIMID. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does REVLIMID Cause?
Pneumonia (652)
Plasma cell myeloma (632)
Death (565)
Diarrhoea (508)
Thrombosis (484)
Fatigue (448)
Platelet count decreased (362)
Full blood count decreased (352)
Deep vein thrombosis (332)
Pancytopenia (319)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which REVLIMID Alternatives Have Lower Lung neoplasm malignant Risk?
REVLIMID vs REVOLADE
REVLIMID vs REVUMENIB
REVLIMID vs REYATAZ
REVLIMID vs REZAFUNGIN
REVLIMID vs RIBASPHERE